Procurement Services Update September 2016
View this email in your browser
What's New
Also available in:

Good to Know

The Ministry of Health and Social Security Institute of El Salvador have partnered on reproductive health supplies with UNFPA for many years.

The savings achieved through UNFPA's purchasing capacity have also enabled the government to maximize limited resources.
Keep Up With Us
UNFPA Procurement
Product Catalog
Budget Planner
Lead Time Calculator
Email Us

Improvements to the UNFPA product catalog 

The UNFPA Procurement Service Branch (PSB) is pleased to announce new improvements to the product catalog.  

UNFPA has been a willing partner with WHO and others in increasing the availability of quality and affordable reproductive health medicines. UNFPA has updated the product catalog to give more prominence to the variety of options available, including hormonal contraceptives. By using International Nonproprietary Names* (INN) of hormonal contraceptives rather than brand names, users get a better overview of the available choices.

The improvements to the catalog include:

  • New item IDs which correspond to the INNs

  • Simplified search functions - based on INNs

  • Easier comparison of alternatives - offering detailed product information such as price, shelf life, and lead-time to identify the best option

  • Better identification of cost savings by aligning available options without the influence of brand names

Not all hormonal contraceptive LTAs have been duly signed and more products will be added as they become available.

For more information about the improvements, feel free to contact the UNFPA Procurement Services Branch at

*Each INN is a unique name that is used to identify pharmaceutical substances and is globally recognized.
To assist with the transition to International Nonproprietary Names (INNs), UNFPA has developed a Hormonal Contraceptives information sheet.  

The sheet provides details of the old item IDs, the new item IDs, the item compositions, and the suppliers of all hormonal contraceptives found in the product catalog.

UNFPA accelerates progress towards universal access in Angola

The UNFPA Angola country office has been instrumental in the signing of a Third Party Procurement (TPP) agreement amounting to over $4 million.

The agreement is the first of its kind since UNFPA began operations in the country in 1978. Signed with the Ministry of Health (MOH) and funded by the World Bank, this memorandum  of  understanding 

(MOU), has been established ​ for the procurement of reproductive health medicines, equipment, and paediatric products for the entire country.

With a population of 25 million people, maternal mortality remains a major public health concern in Angola. The total fertility rate is estimated at 5.7 children per woman with an estimated 460 deaths per 100,000 live births. The work of UNFPA in the country is focused on advocacy for increased availability and use of integrated sexual and reproductive health services (including family planning, maternal health, and HIV) that are gender-responsive and meet human rights standards for quality of care and equity in access.

The signing of this new agreement provides a major opportunity for UNFPA to continue to accelerate progress towards universal access to sexual and reproductive health, voluntary family planning and safe motherhood in Angola.

For information about the agreement, please contact UNFPA at

Increasing access to life-saving reproductive health medicines

Three new sources of reproductive health medicines have recently been prequalified by WHO.
  • Mifepristone - 200mg - Tablets 
  • Levonorgestrel - 30µg - Tablets 
  • Magnesium sulfate heptahydrate - 500mg/ml - Injection

The medicines, which will soon be available for procurement via the UNFPA product catalog, provide additional access to much-needed quality assured medicines.

Life-saving commodities such as these are often inaccessible to vulnerable populations resulting in a number of women dying from preventable and treatable causes. Furthermore, without access to essential family planning commodities, millions of women run the risk of unintended pregnancies and are unable to exercise their basic human right to determine the number and spacing of their children.

As the lead agency for delivering a world where every pregnancy is wanted, every childbirth is safe, and every young person's potential is fulfilled, UNFPA, together with WHO will continue to work towards addressing commodity-related gaps and ensuring access to quality assured life-saving reproductive health medicines.

For questions about these newly prequalified reproductive health medicines, please contact UNFPA at

Generic or innovator medicine - What's the difference? 

What exactly is the difference between an innovator and a generic medicine?

As UNFPA continues to advocate for the use of generic medicines in order to increase access to reproductive health medicines, we have produced a handy little factsheet to help clear up any confusion.

For more information, feel free to view the generic medicine factsheet.  

UNFPA Supplies: Good Governance for Medicines available in Spanish

UNFPA Supplies is pleased to announce that the e-course on Good Governance for Medicines is now available in Spanish. 

The goal of the programme is to contribute to health system strengthening and the prevention of corruption and wastage by promoting good governance in the pharmaceutical sector. 

The course is currently available in English and Spanish, with French soon to be available. 
Register for the course, or for more information about this course or other available courses, please visit the UNFPA Supplies Learning Zone

United Nations Population Fund

Procurement Services Branch
Marmorvej 51
DK-2100 Copenhagen

UNFPA Procurement Services partners with governments, NGOs and UN organizations to improve access to quality assured supplies in a cost effective and reliable way. To learn more, visit • Contact us at • Subscribe • Unsubscribe

Copyright © 2016 UNFPA Procurement Services Branch
All rights reserved

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
UNFPA, Procurement Services Branch · Mamorvej 51 · Copenhagen 2100 · Denmark

Email Marketing Powered by Mailchimp